Clinical trial
Evaluation of a Diabetes Vaccine in Newly Diagnosed Diabetics
NCT00057499 · National Institute of Allergy and Infectious Diseases (NIAID), NIH · Completed
Key facts
| NCT number | NCT00057499 |
|---|---|
| Title | Evaluation of a Diabetes Vaccine in Newly Diagnosed Diabetics |
| Official title | Autoantigen Vaccination in Human Type 1 Newly Diagnosed Diabetes Mellitus |
| Lead sponsor | National Institute of Allergy and Infectious Diseases (NIAID), NIH |
| Collaborators | Immune Tolerance Network (ITN) |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Insulin-dependent Diabetes Mellitus, Diabetes Mellitus |
| Intervention type | Biological |
| Interventions | IBC-VS01, IBC-VS01 placebo |
| Enrollment | 12 |
| Start date | Mar 1, 2003 |
| Primary completion | Mar 1, 2007 |
| Completion | Mar 1, 2007 |
| First posted | Apr 4, 2003 |
| Last update posted | Feb 8, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: